GNAI2 and breast carcinoma: Although GNAI2 has been linked to resistance in trastuzumab-treated breast cancer [62], no previous studies have addressed the association between GNAI gene expression and chemoresistance in COAD, highlighting the novelty of this observation and its therapeutic relevance.